NCT00263003View on ClinicalTrials.gov

Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

June 30, 2005

Conditions

Hypertension

Interventions

DRUG

Irbesartan/hydrochlorothiazide

DRUG

Irbesartan

Trial Locations (1)

Unknown

Sanofi-Aventis, Taipei

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY